Latest Insider Transactions at Y M Abs Therapeutics, Inc. (YMAB)
This section provides a real-time view of insider transactions for Y M Abs Therapeutics, Inc. (YMAB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Y-mAbs Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Y-mAbs Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 16
2025
|
Laura Hamill |
SELL
Sale (or disposition) back to the issuer
|
Direct |
25,080
-100.0%
|
-
|
|
Sep 16
2025
|
Laura Hamill |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
5,825
-100.0%
|
$46,600
$8.6 P/Share
|
|
Sep 16
2025
|
Biotech Ap S Wg |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
4,559,233
-100.0%
|
$36,473,864
$8.6 P/Share
|
|
Sep 16
2025
|
Ashu Tyagi |
SELL
Sale (or disposition) back to the issuer
|
Direct |
25,080
-100.0%
|
-
|
|
Sep 16
2025
|
Ashu Tyagi |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
5,825
-100.0%
|
$46,600
$8.6 P/Share
|
|
Sep 16
2025
|
David N Gill |
SELL
Sale (or disposition) back to the issuer
|
Direct |
30,905
-100.0%
|
$247,240
$8.6 P/Share
|
|
Sep 16
2025
|
Peter P. Pfreundschuh EVP, CFO and Treasurer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
77,800
-100.0%
|
-
|
|
Sep 16
2025
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
127,681
-100.0%
|
$1,021,448
$8.6 P/Share
|
|
Sep 16
2025
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
60,235
-100.0%
|
-
|
|
Sep 16
2025
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
245,486
-100.0%
|
$1,963,888
$8.6 P/Share
|
|
Sep 16
2025
|
Joris Wilms SVP & CHIEF OPERATING OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
39,301
-100.0%
|
-
|
|
Sep 16
2025
|
Joris Wilms SVP & CHIEF OPERATING OFFICER |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
12,799
-100.0%
|
$102,392
$8.6 P/Share
|
|
Sep 16
2025
|
Michael J Rossi PRESIDENT & CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
129,101
-100.0%
|
-
|
|
Sep 16
2025
|
Michael J Rossi PRESIDENT & CEO |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
7,982
-100.0%
|
$63,856
$8.6 P/Share
|
|
Sep 16
2025
|
James Healy |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
2,194,278
-100.0%
|
$17,554,224
$8.6 P/Share
|
|
Sep 16
2025
|
James Healy |
SELL
Sale (or disposition) back to the issuer
|
Direct |
25,080
-100.0%
|
-
|
|
Sep 16
2025
|
James Healy |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
31,603
-100.0%
|
$252,824
$8.6 P/Share
|
|
Sep 16
2025
|
John La Rocca SVP, General Counsel & Secry |
SELL
Sale (or disposition) back to the issuer
|
Direct |
21,500
-100.0%
|
-
|
|
Sep 16
2025
|
Johan Wedell Wedellsborg |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
4,559,233
-100.0%
|
$36,473,864
$8.6 P/Share
|
|
Sep 16
2025
|
Johan Wedell Wedellsborg |
SELL
Sale (or disposition) back to the issuer
|
Direct |
25,080
-100.0%
|
-
|
|
Sep 16
2025
|
Johan Wedell Wedellsborg |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
5,825
-100.0%
|
$46,600
$8.6 P/Share
|
|
Jun 30
2025
|
David N Gill |
BUY
Grant, award, or other acquisition
|
Direct |
25,080
+44.8%
|
-
|
|
Jun 30
2025
|
James Healy |
BUY
Grant, award, or other acquisition
|
Direct |
25,080
+30.67%
|
-
|
|
Jun 30
2025
|
Johan Wedell Wedellsborg |
BUY
Grant, award, or other acquisition
|
Direct |
25,080
+44.8%
|
-
|
|
Jun 30
2025
|
Ashu Tyagi |
BUY
Grant, award, or other acquisition
|
Direct |
25,080
+44.8%
|
-
|
|
Jun 30
2025
|
Laura Hamill |
BUY
Grant, award, or other acquisition
|
Direct |
25,080
+44.8%
|
-
|
|
Jun 03
2025
|
Thomas Gad CHIEF BUSINESS OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
103,000
+25.2%
|
$206,000
$2.0 P/Share
|
|
Mar 07
2025
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
10,810
-5.06%
|
$54,050
$5.23 P/Share
|
|
Mar 07
2025
|
Michael J Rossi PRESIDENT & CEO |
SELL
Open market or private sale
|
Direct |
3,917
-2.78%
|
$19,585
$5.2 P/Share
|
|
Jan 17
2025
|
Peter P. Pfreundschuh EVP, CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
31,800
+29.01%
|
-
|
|
Jan 17
2025
|
Michael J Rossi PRESIDENT & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
105,300
+42.75%
|
-
|
|
Jan 17
2025
|
Joris Wilms SVP & CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
21,500
+29.21%
|
-
|
|
Jan 17
2025
|
Thomas Gad CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
32,000
+13.03%
|
-
|
|
Jan 17
2025
|
John La Rocca SVP, General Counsel & Secry |
BUY
Grant, award, or other acquisition
|
Direct |
21,500
+50.0%
|
-
|
|
Sep 19
2024
|
Thomas Gad CHIEF BUSINESS OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
22,831
+11.17%
|
$91,324
$4.38 P/Share
|
|
Sep 16
2024
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Indirect |
30,000
-30.71%
|
$360,000
$12.97 P/Share
|
|
Sep 13
2024
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Indirect |
65,000
-39.96%
|
$845,000
$13.47 P/Share
|
|
Aug 28
2024
|
Torben Lund Hansen SVP & CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
50,000
-58.41%
|
$750,000
$15.37 P/Share
|
|
Aug 28
2024
|
Torben Lund Hansen SVP & CHIEF TECHNICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+36.87%
|
$200,000
$4.38 P/Share
|
|
Aug 26
2024
|
Joris Wilms SVP & CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
5,000
-14.04%
|
$70,000
$14.69 P/Share
|
|
Jul 12
2024
|
Peter P. Pfreundschuh EVP, CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
46,000
+50.0%
|
-
|
|
Jun 11
2024
|
Ashu Tyagi |
BUY
Grant, award, or other acquisition
|
Direct |
3,495
+37.5%
|
-
|
|
Jun 11
2024
|
David N Gill |
BUY
Grant, award, or other acquisition
|
Direct |
3,495
+37.5%
|
-
|
|
Jun 11
2024
|
James Healy |
BUY
Grant, award, or other acquisition
|
Direct |
3,495
+9.96%
|
-
|
|
Jun 11
2024
|
Johan Wedell Wedellsborg |
BUY
Grant, award, or other acquisition
|
Direct |
3,495
+37.5%
|
-
|
|
Jun 11
2024
|
Laura Hamill |
BUY
Grant, award, or other acquisition
|
Direct |
3,495
+37.5%
|
-
|
|
Jun 11
2024
|
Mary Tagliaferri Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,495
+30.0%
|
-
|
|
Jun 11
2024
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Indirect |
35,000
-17.71%
|
$420,000
$12.0 P/Share
|
|
Jun 10
2024
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Indirect |
35,000
-15.04%
|
$420,000
$12.03 P/Share
|
|
Jun 10
2024
|
Gerard Ber Director |
SELL
Open market or private sale
|
Direct |
722
-30.99%
|
$8,664
$12.0 P/Share
|